#504: From Conventional to Intelligent: Redefining Pharmacovigilance with AI and Global Collaboration
Tuesday, June 16, 2026 10:15 AM to 11:30 AM · 1 hr. 15 min. (America/New_York)
118AB
01: ClinSafety-PV-RM03: Data-Tech-AI
Information
This session traces the evolution of PV innovation: from algorithms tailored to vulnerable groups, to FDA pilots applying AI at scale, to regulatory guidance ensuring readiness and global harmonization for next-generation safety systems.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Artificial Intelligence
Learning Objectives
Identify algorithmic innovations that address signal detection challenges in vulnerable populations; Examine how AI is being piloted to extend these methods into large-scale pv workflows with transparency and oversight; Describe regulatory approaches that translate methodological and technological advances into practice through validation and international harmonization.
Speakers
Daniele Sartori
Senior Pharmacovigilance ScientistUppsala Monitoring Centre (UMC)
Ju-Young Shin
ProfessorSungkyunkwan University
Gerald Dal Pan
Director, Office of Surveillance and Epidemiology, CDERFDA
Raymond Kassekert
Executive Director, PV Systems ManagementGSK
Soojung Sohn
PresidentKorea Institute of Drug Safety and Risk Management (KIDS)IB
Isabella Balallai
DirectorBrazilian Immunization Society